1st PMPPC Conference

9-11 November 2016


Program

Download
poster

Wednesday 9 November

09:00-09:05

Manel Puig

Director, IGTP, Barcelona, Spain
Welcome Remarks

09:05-09:45

Session 1: Gastroinstestinal Cancer (I)Chair: Manuel Perucho

09:05-09:45

Andrew Feinberg

U. John Hopkins, Baltimore, USA
Key Note Speech
Epigenetic Modulators, Modifiers, and Mediators in Cancer

09:45-10:15

Manuel Perucho

PMPPC, IGTP, Barcelona, Spain
DNA methylation, aging, and colon cancer

10:15-10:45

Gabriel Capellà

ICO, Idibell, Barcelona, Spain
GI Hereditary Cancer: Lessons learnt, challenges ahead

10:45-11:00

Coffee break 

11:00-13:00

Session 2: Lung Cancer (I)Chair: Jun Yokota

11:00-11:30

Takashi Kohno

NCRI, Tokyo, Japan
Gene Aberrations for Precision Medicine of Lung Cancer

11:30-12:00

Jun Yokota

PMPPC, IGTP, Barcelona, Spain
MYC Targeting as a Therapeutic Strategy of Small Cell Lung Cancer

12:00-12:30

Montse Sánchez Céspedes

PEBC, Idibell, Barcelona, Spain
Novel determinants of response to epigenetic and immuno-related therapies in lung cancer

12:30-13:00

Short talks selected from submitted abstracts

13:00-14:30

Lunch and Poster Session

14:30-16:00

Session 3: Endocrine Tumors and Cancers (I)Chair: Manel Puig

14:30-15:00

Massimo Terzolo

U. Torino, Italy
Adrenal cancer: from the bench to the bedside

15:00-15:30

Mireia Jordà

PMPPC, IGTP, Barcelona, Spain
Dynamics of DNA methylation profiles in the progression of thyroid cancer: a new source of prognostics markers

15:30-16:00

Alberto Cascón

CNIO, Madrid, Spain
Use of OMICs and NGS in the identification of pheochromocytoma/ paraganglioma susceptibility

16:30-18:00

Session 4: GlycomicsChair: Fumi Yamamoto

16:30-17:00

Fumi Yamamoto

PMPPC, IJC, Barcelona, Spain
An Introduction to glycomics to study glycogenes/glycosyltransferases/glycans:genetic, physiological, pathological, and evolutionary aspects

17:00-17:30

Henrik Clausen

(U. Copenhagen, Denmark)
Aberrant O-glycoproteins may serve as cancer-specific immunotargets 

17:30-18:00

Ten Feizi

Imperial College London, United Kingdom
Carbohydrate microarrays for assignments and exploitation of cancer-associated epithelial antigens

Thursday 10 November

09:00-10:30

Session 5: Gastrointestinal Cancer (II)Chair: Miquel A. Peinado

09:00-09:30

Miquel A. Peinado

PMPPC, IGTP, Barcelona, Spain
Epigenomic modularity in colorectal cancer
 

09:30-10:00

Tatsuhiro Shibata

NCRI, Tokyo, Japan
Genomic and transcriptomic analysis of billary tract cancer

10:00-10:30

Eduard Batlle

IRB, Barcelona, Spain
A stromal gene program drives metastasis in colorectal cancer

10:30-11:00

Fast Track Presentations by Selected Posters 

11:00-11:30

Coffee break and Poster Session

11:30-13:00

Session 6: Lung Cancer (II)Chair: Rafael Rosell

11:30-12:00

Henrik Ditzel

University of S. Denmark, Odense University Hospital, Denmark
Convergent AKT activation in EFGR TKI resistant lung cancer

12:00-12:30

Rafael Rosell

PMPPC, ICO, IGTP, Barcelona, Spain
YAP-NOTCH signaling rebound as a compensatory response to gefitinib or osimertinib theraphy in EFGR mutant long cancer

12:30-13:00

Niki Karachaliou

Hospital Universitari Dexeus, Barcelona, Spain
MET-dependent activation of STAT3 as a mediator of resistance to MEK inhibitors in KRAS-mutant lung cancer

13:00-14:30

Lunch and Poster Session

14:30-16:00

Session 7: Cancer MicrobiomicsChair: Roger Paredes

14:30-15:00

Roger Paredes

Irsi-Caixa, Barcelona, Spain
The diseased human microbiome: experience from HIV infection

15:00-15:30

Esther Molina

CNIO, Madrid Spain
Pancreatic cancer in the microbiome era: further unraveling its complex etiology

15:30-16:00

Xavier Aldeguer

Hospital Josep Trueta, Girona, Spain
Colorectal cancer prediction

16:00-16:30

Coffee break

16:30-18:00

Session 8: Endocrine Tumours and Cancers (II)Chair: Susan Webb, Spain

16:30-17:00

Gerald Raverot

Centre Hospitalier Universitaire de Lyon, France
Agressive pituitary tumors

17:00-17:30

Justo Castaño

IMIBYC, Córdoba, Spain 
Molecular signatures of neuroendocrine tumors

17:30-18:00

Lorenzo Pasquali

PMPPC, IGTP, Barcelona, Spain
Regulation of pancreatic islet cell indentity

Friday 11 November

09:00-10:30

Session 9: LeukemiasChair: Francesc Solé

09:00-09:30

Ramón Mangues

IJC, Campus Sant Pau, Barcelona, Spain
Protein nanoparticles for targeted drug delivery to metastasis initiating cells

09:30-10:00

Marcus Buschbeck

PMPPC, IJC Campus ICO-GTiP, Badalona, Spain
Histone variants link genome architecture and metabolism

10:00-10:30

Pablo Menéndez

IJC, Campus Clínico-UB, Barcelona, Spain
Infant proB Acute Lymphoblastic Leukemia MLL-AF4+: an outlier pediatric cancer/developmental disease

10:30-11:00

Short talks selected from submitted abstracts

11:00-11:30

Coffee break

11:30-12:45

Cancer EpigeneticsChair: Marcus Buschbeck

11:30-12:00

Andrei Chernov

Sanford Burnham Prebys Medical Discov. Inst., La Joll, USA
Microbiome DNA methyltransferases and cancer epigenetic landscape 

12:00-12:40

Manel Esteller

PEBC, Idibell, Barcelona, Spain
Closing Conference
Cancer Epigenetics: From Knowledge to Applications

12:40-12:45

Closing Remarks & Adjourn: Manuel Perucho

Download
poster